Acromegaly Treatment Market
According to Intent Market Research, the Acromegaly Treatment Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 10.2% to touch USD 2.9 billion by 2030. The Acromegaly Treatment Market is dominated by key players such as Alexion Pharmaceuticals (AstraZeneca), Amgen Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, Merck & Co., Inc., Novartis International AG, and Pfizer Inc.